- Home
- / SHINEWAY PHARMACEUTICAL
SHINEWAY PHARMACEUTICAL
Stock Price
$9.5
2024-10-29
Market Capitalization
$6.9 B
2024-10-29
Revenue
¥3.1 B
FY, 2025
SHINEWAY PHARMACEUTICAL Summary
Company Summary
- Overview
- SHINEWAY PHARMACEUTICAL is a pharmaceutical company. It offers cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology.
- Type
- Public
- Status
- Active
- Founded
- 2002
- Website
- http://www.shineway.com
- Cybersecurity rating
Table of Contents
SHINEWAY PHARMACEUTICAL Financials
Summary Financials
- Revenue (FY, 2025)
- ¥3.1B
- Gross profit (FY, 2025)
- ¥2.6B
- Net income (FY, 2025)
- ¥949.9M
- Cash (FY, 2025)
- ¥7.2B
- EBIT (FY, 2025)
- ¥917.4M
- Enterprise value
- $109.3M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026